Chronic Kidney Disease-Associated Pruritus, Still a Vexing Problem

Area of Science:

• Nephrology
• Dermatology
• Internal Medicine

Background:

• Chronic kidney disease-associated pruritus (CKD-aP), previously known as uremic pruritus, is a prevalent and distressing condition affecting up to 60% of dialysis patients.
• CKD-aP significantly impairs quality of life, leading to sleep disturbances and is linked to increased mortality rates in patients with chronic kidney disease (CKD).
• The condition is also observed in non-dialysis CKD patients (stages 3-5), with prevalence increasing alongside declining kidney function, age, and comorbidities.

Discussion:

• The complex pathophysiology of CKD-aP suggests involvement of multiple factors and molecular pathways.
• Underdiagnosis and undertreatment are significant issues, indicating a gap in current clinical management strategies for pruritus in CKD patients.
• The association with worse outcomes underscores the importance of recognizing and addressing CKD-aP.

Key Insights:

• CKD-aP is a common, severe symptom in chronic kidney disease patients, impacting both quality of life and survival.
• The prevalence and severity of pruritus correlate with kidney function decline.
• Effective diagnostic and therapeutic strategies for CKD-aP remain critical.

Outlook:

• Further research into the multifaceted pathophysiology of CKD-aP is essential for developing targeted treatments.
• Improved diagnostic tools and treatment protocols are needed to address the underdiagnosis and undertreatment of CKD-aP.
• Addressing CKD-aP is crucial for improving patient outcomes and survival in the chronic kidney disease population.